RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 119 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $175 | – | 1,000 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 1,000 | +300.0% | 0.00% | – |
| Q1 2022 | $1,000 | -50.0% | 250 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $2,000 | 0.0% | 250 | +150.0% | 0.00% | 0.0% |
| Q3 2021 | $2,000 | -33.3% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $3,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |